2h
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Investor's Business Daily on MSN
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
Tempus AI stock surged to a record-high Monday after the Food and Drug Administration cleared its new device to help ...
Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...
Tempus AI Inc. shares rose after it said it received 510 (k) clearance from the Food and Drug Administration for its RNA-based in vitro diagnostic device. Its stock recently rose 5.2% to $92.85 in ...
Samples are commonly stored in a way that degrades RNA. Scientists are devising new ways to overcome this obstacle for RNA sequencing. RNA is more subject to degradation than DNA, whether chemical, ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...
Years of experiments and databases filled with RNA-seq results belie the simple reality that, until fairly recently, it was impossible to analyze RNA directly. The RNA-seq studies performed with ...
AZoLifeSciences on MSN
Advanced Statistical Method Reduces Noise in Single-Cell RNA-Sequencing Data
The world of cells is surprisingly noisy. Each cell carries unique genetic information, but when we try to measure cellular ...
Background Molecular genetic diagnoses are critical to prevention and treatment of inherited polyposis and colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback